Abiopharma

🔍 Schlesinger Allyson Katz (Executive)

Company: Columbia Financial, Inc. (CLBK)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 10,852 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: D | equity_swap_involved: 0 | shares_owned_after: 68,623.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,309 shares of Common Stock at $19.25 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 67,314.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Stock-Based Deferral Plan | shares_owned_after: 13,543.37
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 7,753.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By SERP | shares_owned_after: 7,130.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By SIM | shares_owned_after: 4,683.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Stock Award III | shares_owned_after: 11,520.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Stock Award IV | shares_owned_after: 12,288.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Stock Award V | shares_owned_after: 12,574.00 | Footnotes: F6
• Holds 155,294 shares of Stock Options (right to buy) at $15.6 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2029-07-23 | Exercise: 2020-07-23 | shares_owned_after: 155,294.00 | Footnotes: F7
• Holds 12,632 shares of Stock Options (right to buy) at $15.94 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2033-05-01 | Exercise: 2024-05-01 | shares_owned_after: 12,632.00 | Footnotes: F7
• Holds 9,292 shares of Stock Options (right to buy) at $16.49 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2034-03-06 | Exercise: 2025-03-06 | shares_owned_after: 9,292.00 | Footnotes: F8
• Holds 21,289 shares of Stock Options (right to buy) at $16.23 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2035-03-03 | Exercise: 2026-03-03 | shares_owned_after: 21,289.00 | Footnotes: F9
• Holds 21,364 shares of Stock Options (right to buy) at $18.28 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2036-03-02 | Exercise: 2027-03-02 | shares_owned_after: 21,364.00 | Footnotes: F10

Footnotes:

• F1: Represents the forfeiture of performance-based restricted stock granted to the reporting person on May 1, 2023 that were eligible to vest based on certain performance objectives. On May 1, 2026 the Company determined that, based on the Company's performance over the applicable performance period, 2,171 shares would vest and 10,852 shares would be forfeited.
• F2: The number of shares held directly includes certain shares that were previously held by Stock Award and that have subsequently vested.
• F3: This form reflects increases in beneficial ownership resulting from exempt acquisitions pursuant to rule 16b-3(c).
• F4: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.
• F5: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.
• F6: Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 2, 2029.
• F7: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
• F8: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.
• F9: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.
• F10: Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 2, 2027.